GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,443.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 1,766.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,099.70m
  • Volume: 2,150,158
  • Market Cap: £59,159m
  • RiskGrade: 129
  • Beta: 0.00

Sunday newspaper round-up: US-China, Aerospace, Pharma

By Digital Look

Date: Sunday 11 May 2025

LONDON (ShareCast) - (Sharecast News) - The US president said talks with China that were taking place in Geneva had achieved a "total reset" in the two countries' trade relations. Without elaborating, Donald Trump said that great progress had been made and that they wanted to see an opening up of China to American businesses. The negotiations were scheduled to continue on Sunday. - Guardian


The UK is near to reaching an agreement with Donald Trump that would grant an exemption from US tariffs to the country's £40bn aerospace sector. The business secretary also opened the door to an increase in quotas for British-made automobiles that can opt for a lower 10% US import tax. - The Sunday Times

As part of a wider trade deal, ministers are reviewing the controversial tax on medicines that pharma groups claim makes Britain "uninvestable". Companies including AstraZeneca and GSK do not yet know which tariffs, if any, they will have to pay. The US president has threatened to impose a 25% levy on UK drugs going to the US. - The Financial Mail on Sunday

The heads of companies paid billions of pounds by the government to house asylum seekers are set to see bumper increases in their pay. That is because asylum accommodation is expected to hit £15bn over a decade, three times what had been initially estimated. The companies are Mears, Serco and Clearsprings Ready Homes. According to the National Audit Office, the cost of asylum accommodation in 2024-25 alone hit £1.67bn, of which hotels accounted for 76%. - Financial Mail on Sunday

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,443.00p
Change Today -5.00p
% Change -0.35 %
52 Week High 1,766.50p
52 Week Low 1,264.00p
Volume 2,150,158
Shares Issued 4,099.70m
Market Cap £59,159m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Price Trend
13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Income
74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 28-May-2025

Time Volume / Share Price
14:26 1,193 @ 1,443.00p
14:26 531 @ 1,443.00p
14:26 490 @ 1,443.00p
14:26 203 @ 1,443.00p
14:26 900 @ 1,443.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page